mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.004 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.004 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.005 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.005 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |